About 25–50% of men diagnosed with prostate cancer have low-grade disease, based on the PSA levels and clinical staging of prostate biopsies, and the majority of these patients are assigned to active surveillance without aggressive procedures, such as prostatectomy [6]. Here, KLK3 is linked to prostate carcinoma.